A pharmaceutical composition for preventing or treating female climacteric syndromes comprising Loganin which increases the concentration of estradiol (17β-estradiol, E2) in the blood of a menopausal mouse model and has shown efficacies such as an increase in the estrogen receptor alpha expression in the uterus, which remedies uterine contraction and degeneration, and decreases in the accumulation and the size of adipocytes in liver and the abdominal adipose tissues and the liver and weight loss, a derivative thereof or a pharmaceutically acceptable salt thereof as an active ingredient.
一种用于预防或治疗女性更年期综合征的药物组合物,由 Loganin 组成,它能增加更年期小鼠模型血液中
雌二醇(17β-
雌二醇,E2)的浓度,并具有增加子宫中
雌激素受体α表达等功效、本发明的活性成分是其衍
生物或其药学上可接受的盐,它能改善子宫收缩和退化,减少肝脏、腹部脂肪组织和肝脏中脂肪细胞的堆积和体积,减轻体重。